Andera Partners
13F holdings for Q2 2026 · PARIS, I0 · filed July 22, 2026
Andera Partners reported $206M in 13F securities across 8 holdings for Q2 2026, in a Form 13F filed July 22, 2026. The largest positions were Kestra Med Technologies LTD (33.6%), MLYS (20.8%), AVLN (14.8%). Reported value rose 16.7% from the quarter before. It opened 1 new position, added to 2, trimmed 1 and sold out of 0.
- 13F value Q2 2026
- $206M
- Holdings
- 8
- Change vs prior quarter
- +16.7%
- Rank by 13F value
- #6,434
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Top holdings
| Stock | Value | Weight | Shares | Change in shares | Move |
|---|---|---|---|---|---|
| Kestra Med Technologies LTD | $69.4M | 33.6% | 2,728,679 | +1.2% | Added |
| MLYS Mineralys Therapeutics Inc. | $42.9M | 20.8% | 1,591,917 | 0% | Unchanged |
| AVLN Avalyn Pharma Inc. | $30.6M | 14.8% | 929,824 | New | New |
| AGMB AgomAb Therapeutics NV | $20.0M | 9.7% | 1,538,702 | 0% | Unchanged |
| EVMN Evommune Inc. | $18.5M | 9.0% | 1,391,990 | -26.6% | Trimmed |
| IVA Inventiva S.A. | $13.7M | 6.7% | 3,633,181 | +99.8% | Added |
| ABVX Abivax SA | $10.4M | 5.0% | 78,125 | 0% | Unchanged |
| Nyxoah S A | $882K | 0.4% | 522,057 | 0% | Unchanged |
Share positions only, at the value reported for the end of Q2 2026. Weight is the share of $206M in share positions; options and bonds count in the 13F value but not here.
Biggest buys in Q2 2026
- AVLN Avalyn Pharma Inc. New+$30.6M
- IVA Inventiva S.A. Added+$6.9M
- Kestra Med Technologies LTD Added+$852K
Biggest sells in Q2 2026
- EVMN Evommune Inc. Trimmed-$6.7M
The change in shares since Q1 2026, adjusted for stock splits and priced at the Q2 2026 value per share. 1 new, 2 added, 1 trimmed, 0 sold out.
Sector mix
- Health Care66.0%
- Not listed with us34.0%
13F value by quarter
Schedule 13D and 13G filings by Andera Partners
Stakes above 5% of a company, filed within days rather than once a quarter.
- 2025-11-17EVMN SCHEDULE 13G filed by Evommune Inc.Schedule 13G
Questions about Andera Partners
- What does Andera Partners own?
- In its Form 13F for Q2 2026, Andera Partners reported 8 holdings worth $206M. The five largest were Kestra Med Technologies LTD, MLYS, AVLN, AGMB, EVMN.
- What did Andera Partners buy and sell in Q2 2026?
- Andera Partners opened 1 new position, added to 2, trimmed 1 and sold out of 0 compared with the quarter before.
- When did Andera Partners file its latest 13F?
- Form 13F is due 45 days after each quarter ends. The Q2 2026 report was due August 14, 2026 and was filed July 22, 2026.
From Form 13F filed by Andera Partners (SEC CIK 0001757283) for the quarter ended June 30, 2026, via the SEC's Form 13F data sets. Amendments that restate a report replace it; amendments that add holdings are included. View on SEC EDGAR · All funds